Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: A randomized, placebo-controlled trial
Context The role of systemic corticosteroids in the treatment of infants and toddlers with acute viral respiratory infection-induced lower airway disease has been controversial, especially for initial occurrences.
PII: S0022-3476(04)00355-5
doi:10.1016/j.jpeds.2004.04.041
© 2004 Elsevier Inc. All rights reserved.
